A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new research warns. The findings highlight the need to develop new drugs and treatment regimens for the lethal brain infection, which kills around 180,000 people each year.
from Top Health News -- ScienceDaily https://ift.tt/38jpFMn
No comments:
Post a Comment